Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Pharmacology

Background:

• DNA-damaging chemotherapeutics are a cornerstone of cancer therapy.
• These agents induce DNA damage directly or indirectly.
• Their efficacy relies on the cellular response to DNA damage, not solely the damage itself.

Discussion:

• The cellular response to DNA damage is crucial for the targeted effect of chemotherapeutics on cancer cells versus normal cells.
• Mechanisms include inducing DNA strand breaks, base modification, and altering chromatin structure.
• Inhibition of chromatin-modifying enzymes is another therapeutic strategy.

Key Insights:

• Cellular response mechanisms dictate the specificity of DNA-damaging anticancer drugs.
• Targeting cellular responses can enhance therapeutic efficacy and reduce side effects.
• Understanding these responses is vital for developing novel cancer treatments.

Outlook:

• Future research should focus on elucidating specific cellular response pathways to DNA damage.
• Developing drugs that modulate these responses could lead to more effective and selective cancer therapies.
• This area holds promise for advancing personalized cancer medicine.